<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2018</year>
	    <month>>July-September</month>
	    <day></day>
    </pubdate>
    <volume>10</volume>
    <number>3</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>30090207</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>A Feasibility Study to Evaluate Bacillus subtilis as a Host for Producing Recombinant Human Parathyroid Hormone</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Biosynthetic teriparatide (1-34) (TPD) is a N-terminally truncated version of human parathyroid hormone (hPTH). The recombinant form of this polypeptide has been expressed in &lt;em&gt;Escherichia coli (E. coli)&lt;/em&gt; and approved as the first anabolic treatment of osteoporosis in the EU and the USA. Feasibility of expression and secretion of a tag- fused form of TPD into &lt;em&gt;Bacillus subtilis (B. subtilis)&lt;/em&gt; was examined due to several advantages of &lt;em&gt;B. subtilis &lt;/em&gt;over &lt;em&gt;E. coli &lt;/em&gt;in production of recombinant proteins with pharmacological activities.&lt;br /&gt;
Methods: A codon optimized gene containing TPD open reading frame carrying enterokinase site in its upstream was fully synthesized. According to our cloning scheme, this synthetic polynucleotide was used as a template for PCR amplification using engineered primers in such a way that a polyhistidin tag was added in frame to the upstream of the amplicon as well as two restriction sites at its ends. The resulted amplicon, a cassette containing His-tag, enterokinase site and TPD, from 5&amp;rsquo; to 3&amp;rsquo;, was cloned into pTZ57R/T vector and subjected to sequencing.The cassette was then subcloned into pHT43 shuttle vector and transformed into &lt;em&gt;B. subtilis&lt;/em&gt;. Expression of target protein was analyzed by SDS-PAGE and western blotting upon induction by IPTG.&lt;br /&gt;
Results: The accuracy of construction of pHT43-TPD was confirmed by sequencing and restriction map analyses. SDS-PAGE and western blotting results showed that the recombinant fusion form of hPTH was successfully expressed and secreted into cytoplasm and extracellular medium.&lt;br /&gt;
Conclusion: TPD may be successfully expressed and secreted in &lt;em&gt;B. subtilis&lt;/em&gt;; however, optimization of expression conditions is required for enhancing target protein yield.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Bacillus subtilis, hPTH, Teriparatide</keyword>
	<start_page>147</start_page>
	<end_page>151</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=319</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/319.pdf</pdf_url>
	<author_list><author><first_name>Mahdi</first_name><middle_name></middle_name><last_name>Karimi</last_name><suffix></suffix><affiliation>Department of Molecular Genetics, Research Centre for Biosciences and Biotechnology, Malek-Ashtar University of Technology, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1284</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Farida</first_name><middle_name></middle_name><last_name>Behzadian</last_name><suffix></suffix><affiliation>Department of Molecular Genetics, Research Centre for Biosciences and Biotechnology, Malek-Ashtar University of Technology, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1285</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Hamideh</first_name><middle_name></middle_name><last_name>Rouhaninejad</last_name><suffix></suffix><affiliation>Department of Molecular Genetics, Research Centre for Biosciences and Biotechnology, Malek-Ashtar University of Technology, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1286</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Sanaz</first_name><middle_name></middle_name><last_name>Yari</last_name><suffix></suffix><affiliation>Department of Molecular Genetics, Research Centre for Biosciences and Biotechnology, Malek-Ashtar University of Technology, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1287</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

